Craig Venter

Craig Venter
John Craig Venteris an American biotechnologist, biochemist, geneticist, and entrepreneur. He is known for being one of the first to sequence the human genome and the first to transfect a cell with a synthetic genome. Venter founded Celera Genomics, The Institute for Genomic Researchand the J. Craig Venter Institute, and is now CEO of Human Longevity Inc. He was listed on Time magazine's 2007 and 2008 Time 100 list of the most influential people in the world. In 2010, the...
NationalityAmerican
ProfessionScientist
Date of Birth14 October 1946
CountryUnited States of America
As a scientist, I clearly see the potential for harnessing the power of nature.
You can't have life without the genetic code.
For each gene in your genome, you quite often get a different version of that gene from your father and a different version from your mother. We need to study these relationships across a very large number of people.
People think they're making individual decisions for themselves and their family not to get vaccinated. It's not just an individual choice - you're a hazard to society.
I've made money by just trying to do world-class science. That's the goal that we're setting at Celera. If we do world-class science and create new medicine paradigms, the money will more than follow at a corporate level and at a personal level.
If anything, we've learned that we don't think this data's going to be as deterministic as was previously thought, ... There is even more need for this legislation until science catches up with our collective ignorance.
How we understand our own selves and how we work with our DNA software has implications that will affect everything from vaccine development to new approaches to antibiotics, new sources of food, new sources of chemicals, even potentially new sources of energy.
Now that we can read and write the genetic code, put it in digital form and translate it back into synthesized life, it will be possible to speed up biological evolution to the pace of social evolution.
I have a blend of klotho gene variants that have been linked with a lower risk for coronary artery disease and stroke and an advantage in longevity.
Synthetic biology can help address key challenges facing the planet and its population. Research in synthetic biology may lead to new things such as programmed cells that self-assemble at the sites of disease to repair damage.
I've had a very unusual background in science - not the usual route of planning on being a scientist from age 3. I think my story shows that success is more about personal motivation and determination than it is about where you were born or what your economic status was.
Preventative medicine has to be the direction we go in. For example, if colon cancer is detected early - because a person knew he had a genetic risk and was having frequent exams - the surgery is relatively inexpensive and average survival is far greater than 10 years.
I turned 65 last year, and each year I get more and more interested in human health. For most people it happens around age 50, but I've always been a slow learner. It's critical in terms of the cost of health care.
All these names are bigger-than-life names, ... When you see their actual letters and their notebooks, it puts a real stamp of humanity on these people.